Biotech · Private company
Cingulate Therapeutics
Track this companyFree. Adds Cingulate Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline17
- CTx-1301 - Dexmethylphenidate 12.5mgPhase 3 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- CTx-1301 - Dexmethylphenidate 18.75mgPhase 3 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- CTx-1301 - Dexmethylphenidate 25.0mgPhase 3 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- CTx-1301 - Dexmethylphenidate 25mgPhase 3 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- CTx-1301 - Dexmethylphenidate 31.25mgPhase 3 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- CTx-1301 - Dexmethylphenidate 37.5mgPhase 3 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- CTx-1301 - Dexmethylphenidate 50mgPhase 3 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- CTx-1301 - Dexmethylphenidate 6.25mgPhase 3 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- CTx-1301-Dexmethylphenidate 12.5 mg (titration only)Phase 3 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)Phase 3 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- CTx-1301-Dexmethylphenidate 25mg (randomized fixed dose)Phase 3 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- CTx-1301-Dexmethylphenidate 37.5 mg (randomized fixed dose)Phase 3 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- Dexmethylphenidate 40 Mg Oral Capsule, Extended ReleasePhase 2 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- Dexmethylphenidate 5 Mg Oral Capsule, Extended ReleasePhase 2 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- Dexmethylphenidate 50 mg TabletPhase 2 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- Dexmethylphenidate 6.25 mg TabletPhase 2 · ADHDClinicalTrials.gov · fetched Nov 12, 2026
- DexmethylphenidatePhase 1 · Healthy Volunteers in Fed and Fasted StateClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted)PHASE1 · COMPLETED · started Oct 31, 2024ClinicalTrials.gov NCT07119073 · fetched Nov 12, 2026
- Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301PHASE3 · COMPLETED · started Aug 1, 2023ClinicalTrials.gov NCT05286762 · fetched Nov 12, 2026
- Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301PHASE3 · SUSPENDED · started Jul 31, 2023ClinicalTrials.gov NCT05924594 · fetched Nov 12, 2026
- Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.PHASE3 · COMPLETED · started Dec 29, 2022ClinicalTrials.gov NCT05631626 · fetched Nov 12, 2026
- Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy SubjectsPHASE1 · COMPLETED · started Sep 14, 2022ClinicalTrials.gov NCT04449250 · fetched Nov 12, 2026
- CTx-1301 Comparative Bioavailability StudyPHASE1_PHASE2 · COMPLETED · started Dec 6, 2019ClinicalTrials.gov NCT04138498 · fetched Nov 12, 2026